TP Vahl, DA D'Alessio - eid, 2004 - Informa Pharma Science It has been known for at least one century that agents secreted from the
intestine during meal absorption regulates glucose assimilation. Extensive
research during the past three decades has identified two gut hormones, ... Cited by 24 - Related articles - All 4 versions
- ►endojournals.org AB Goldfine, EC Mun, E Devine, R Bernier, M … - Journal of Clinical Endocrinology & Metabolism, 2007 - Endocrine Soc Results: Insulin and C-peptide after the liquid mixed meal were both higher
relative to the glucose level achieved in persons after GB with NG compared with
asymptomatic individuals. Glucagon, glucagon-like peptide 1, and glucose- ... Cited by 22 - Related articles - BL Direct - All 3 versions
- ►diabetesjournals.org K Raun, P von Voss, CF Gotfredsen, V … - Diabetes, 2007 - Am Diabetes Assoc Metabolic effects of the glucagon-like peptide-1 analog liraglutide and the
dipeptidyl peptidase-IV inhibitor vildagliptin were compared in rats made obese
by supplementary candy feeding. Female Sprague-Dawley rats were randomized ... Cited by 16 - Related articles - BL Direct - All 7 versions
MCB Edwards - Annals of Medicine, 2005 - informahealthcare.com Glucagon‐like peptide‐1 (GLP‐1) was first isolated and sequenced twenty
years ago. It has been shown to have many effects in man. GLP‐1 stimulates
insulin secretion, delays gastric emptying, decreases glucagon levels and ... Cited by 11 - Related articles - BL Direct - All 7 versions
- ►endocrinology-journals.org CW Hay, EM Sinclair, G Bermano, E Durward, … - Journal of Endocrinology, 2005 - Soc Endocrinology Glucagon-like peptide-1 (GLP-1) is a peptide hormone secreted from the
enteroendocrine L-cells of the gut and which acts primarily to potentiate the
effects of glucose on insulin secretion from pancreatic ß-cells. It also ... Cited by 10 - Related articles - BL Direct - All 3 versions
T Vilsbøll - Dan Med Bull, 2004 - dadlnet.dk This review has been accepted as a thesis with twelwe previously published
papers, by the University of Copenhagen, April 30, 2004, and defended on
September 17, 2004. ... Department of Internal Medicine F and Clinical ... Cited by 9 - Related articles - Cached - All 5 versions
K Aston-Mourney, J Proietto, S Andrikopoulos - Expert Opin. Investig. Drugs, 2005 - informahealthcare.com Type 2 diabetes is associated with insulin resistance and reduced insulin
secretion, which results in hyperglycaemia. This can then lead to diabetic
complications such as retinopathy, neuropathy, nephropathy and cardio- ... Cited by 5 - Related articles - BL Direct - All 4 versions
P Kuo, CK Rayner, M Horowitz - Clinics in Geriatric Medicine, 2007 - Elsevier Gastric emptying is mildly slowed in healthy aging, although generally remains
within the normal range for young people. The significance of this is unclear,
but may potentially influence the absorption of certain drugs, especially ... Cited by 1 - Related articles - All 15 versions
- ►bentham.org [PDF] SA Doggrell - Reviews on Recent Clinical Trials, 2007 - ingentaconnect.com Abstract: The obesity epidemic in the developed and developing world is being
followed by an epidemic of type 2 diabetes. In type 2 diabetes, subjects cannot
manage glucose properly because they do not produce enough insulin, and the ... Cited by 1 - Related articles - BL Direct - All 5 versions
[CITATION] Management of pancreatic diabetes secondary to chronic pancreatitis
